Epiphany Investing

Searching Out the Optimal Portfolio of “Revelation” Stocks

Exiting Schering Plough, Looking at Going Global

In line with yesterday’s post on some pending changes to the Secular Trends Model Portfolio, I am blowing out the remaining 1850 shares of Schering-Plough in the model. SGP has really just been a floater since the announcement of Merck’s buyout in early March, which initially valued Schering shares at $23.60 in cash and stock.
Since [...]

More on this topic (What's this?)
Merck Stokes M&A Fires with $41.1 Billion Bid for Schering-Plough (Money Morning, 3/9/09)
MRNA (All Allan, 2/23/10)
SEC Probes Trading in Schering (absolutideas, 5/1/09)
Read more on Schering-Plough, Merck at Wikinvest

U.S. Stock Markets Strike Fresh Lows; Cooler Heads Stand Up?

All the major indexes sit at fresh multi-year lows Wednesday, as the crosscurrents of a seemingly endless wave of negative news has uncertainty levels (as measured by the VIX) one push away from new all-time highs.
The Secular Trends Portfolio has given back all the alpha that seemed so well-earned just two weeks ago on Election [...]

A Hungry Blind Man at the Buffet

These are the days that make investors - and economists - and analysts - try to pull their hair out. I suppose some succeed. It’s not that we can’t handle down days; our skin is impervious to them now. But a day like today is rife with contradiction, uncertainty, changing rules, and low rates of [...]

Mid-Day Update - Earnings & Cherry Picking Define the Day

With major indexes essentially flat at mid-day, there doesn’t seem to be any concerted buying of safety names, as evidenced by this screen I ran:
S&P 500 Stocks with forward P/E under 10, Current Ratio over 1.0 trading down today:
105/303 (34%)
S&P 500 stocks with same metrics that are trading up today:
115/294 (39%)
So we’re seeing a [...]

More on this topic (What's this?)
EARNINGS CONFUSION (THE PRAGMATIC CAPITALIST, 3/14/10)
Market In Denial Phase Of Sentiment Cycle (Disciplined Approach to Investing, 3/9/10)
Bristol-Myers Squibb, Two other companies raise dividends (Dividend Growth Investor, 12/28/09)
Read more on S&P 500 (SPX), Net Income, Bristol-Myers Squibb Company at Wikinvest

Adding to Schering-Plough, Freeport McMoRan (FCX, SGP)

I simply cannot ignore these prices. Copper will hopefully be the base metal that leads on forming a bottom, and Schering is just too defensive in its operating segments to be pushed down to these levels.
Adding 1500 share SGP at $13.06
Adding 750 shares FCX at $36.79
Run into the crowd when everyone else is fleeing.
EpiphanyOne

Adding Schering-Plough to Portfolio (SGP)

Details to come after the close; I want to time-stamp a purchase of 1650 shares SGP at $14.95; Schering is a fantastic company, globally diversified and with a nice animal health business.
It’s always darkest right before dawn…Or at least that’s what they say - I honestly don’t know if that’s scientifically true.
EpiphanyOne